Lv33
220 积分 2025-09-11 加入
Long-term Clinical Outcomes and Optimal Treatment Approaches of Degenerative Cervical Spondylosis: A 12-Year Multicenter Retrospective Cohort Study
3小时前
待确认
Health-related quality of life, pain, and symptomatic skeletal events with [¹⁷⁷Lu]Lu-PSMA-617 in patients with progressive metastatic castration-resistant prostate cancer (PSMAfore): an open-label, randomised, phase 3 trial
1天前
已完结
Effect of shenfu injection in patients with septic shock: A systemic review and meta-analysis for randomized clinical trials
9天前
已完结
Shenfu Injection Ameliorates Sepsis - Associated Acute Kidney Injury via Inhibiting Inflammatory Response and Oxidative Stress: A Randomized Controlled Trial
9天前
已关闭
Shenfu injection ameliorates endotoxemia-associated endothelial dysfunction and organ injury via inhibiting PI3K/Akt-mediated glycolysis
9天前
已完结
Empowering PARP inhibition through rational combination: Mechanisms of PARP inhibitors and combinations with a focus on the treatment of metastatic castration-resistant prostate cancer
15天前
已完结
Phase 1 study of HP518, a PROTAC AR degrader in patients with mCRPC: results on safety, pharmacokinetics, and anti-tumor activity
15天前
已完结
Misadministration of 177 Lu-DOTATATE Instead of 177 Lu-PSMA in a Patient With Prostate Cancer: Clinical Implications and Management
15天前
已完结
Dose-Dense Docetaxel and Radium-223 in Bone-Dominant Metastatic Castration-Resistant Prostate Cancer
15天前
已完结
The Impact of Uncommon HRR Alterations as Predictors of Efficacy of PARP Inhibitors in Metastatic Castration-Resistant Prostate Cancer: A Meta-Analysis of Randomized Controlled Trials
15天前
已完结
皖公网安备34019202002308
